PubRank

Eloisa Arbustini

Author PubWeight™ 102.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005 6.93
2 Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2007 6.34
3 Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013 3.50
4 Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005 2.29
5 Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol 2012 2.28
6 [Takotsubo cardiomyopathy: a consensus document]. G Ital Cardiol (Rome) 2008 2.26
7 Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 2009 2.23
8 Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol 2008 1.97
9 Anemia of chronic disease and defective erythropoietin production in patients with celiac disease. Haematologica 2008 1.72
10 Cardiovascular manifestations in men and women carrying a FBN1 mutation. Eur Heart J 2010 1.68
11 A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J 2011 1.67
12 Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations. Pediatrics 2009 1.67
13 Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2010 1.58
14 Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France. Transplantation 2005 1.52
15 Autosomal recessive atrial dilated cardiomyopathy with standstill evolution associated with mutation of Natriuretic Peptide Precursor A. Circ Cardiovasc Genet 2012 1.49
16 Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer 2007 1.40
17 Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy. Eur Heart J 2009 1.35
18 Mitochondrial DNA variant discovery and evaluation in human Cardiomyopathies through next-generation sequencing. PLoS One 2010 1.25
19 Mechanisms of disease: apoptosis in heart failure--seeing hope in death. Nat Clin Pract Cardiovasc Med 2006 1.24
20 Noncompaction of the left ventricle: primary cardiomyopathy with an elusive genetic etiology. Curr Opin Pediatr 2007 1.22
21 Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy. Eur Heart J 2009 1.19
22 Sources of error and interpretation of plaque morphology by optical coherence tomography. Am J Cardiol 2006 1.18
23 Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations. J Cardiovasc Med (Hagerstown) 2009 1.16
24 Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. Hum Mol Genet 2012 1.16
25 Mitochondrial cardiomyopathies: how to identify candidate pathogenic mutations by mitochondrial DNA sequencing, MITOMASTER and phylogeny. Eur J Hum Genet 2010 1.15
26 Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil 2006 1.11
27 Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2012 1.11
28 Risk of dissection in thoracic aneurysms associated with mutations of smooth muscle alpha-actin 2 (ACTA2). Heart 2011 1.08
29 Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defects. Eur J Hum Genet 2006 1.07
30 Loss of lamin A/C expression revealed by immuno-electron microscopy in dilated cardiomyopathy with atrioventricular block caused by LMNA gene defects. Virchows Arch 2003 1.06
31 Prognosis factors in probands with an FBN1 mutation diagnosed before the age of 1 year. Pediatr Res 2011 1.04
32 Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. Eur Heart J 2003 1.01
33 Comprehensive overview of definitions for optical coherence tomography-based plaque and stent analyses. Coron Artery Dis 2014 0.99
34 Total erythrocyte membrane cholesterol: an innocent new marker or an active player in acute coronary syndromes? J Am Coll Cardiol 2007 0.97
35 Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects. J Am Coll Cardiol 2011 0.96
36 High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study. Int J Cardiol 2009 0.96
37 alphaB-crystallin mutation in dilated cardiomyopathies: low prevalence in a consecutive series of 200 unrelated probands. Biochem Biophys Res Commun 2006 0.96
38 Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families. Gastroenterology 2004 0.96
39 In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome. Am J Hum Genet 2012 0.94
40 Sudden anabolic steroid abuse-related death in athletes. Int J Cardiol 2005 0.93
41 Determinants of quality of life in Marfan syndrome. Psychosomatics 2008 0.93
42 A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur Heart J 2013 0.92
43 Genetic predisposition to heart failure. Med Clin North Am 2004 0.91
44 [Diseases associated with lamin A/C gene defects: what the clinical cardiologist ought to know]. Ital Heart J Suppl 2004 0.90
45 Barth syndrome associated with compound hemizygosity and heterozygosity of the TAZ and LDB3 genes. Am J Med Genet A 2007 0.90
46 A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. Ann Neurol 2005 0.89
47 Aneurysm syndromes and TGF-beta receptor mutations. N Engl J Med 2006 0.87
48 Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers. Eur J Heart Fail 2012 0.87
49 Bronchogenic cyst: unexpected finding in a large aneurysm of the pars membranacea septi. J Thorac Cardiovasc Surg 2006 0.87
50 [Atrial standstill: a paralysis of cardiological relevance]. Ital Heart J Suppl 2004 0.86
51 The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy. Europace 2013 0.86
52 A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy. Eur Heart J 2009 0.85
53 Text Mining approaches for automated literature knowledge extraction and representation. Stud Health Technol Inform 2010 0.84
54 Molecular imaging of the cardiac extracellular matrix. Circ Res 2014 0.84
55 Heart transplantation in infants with idiopathic hypertrophic cardiomyopathy. Pediatr Transplant 2008 0.83
56 The shortness of Pygmies is associated with severe under-expression of the growth hormone receptor. Mol Genet Metab 2009 0.82
57 When should cardiologists suspect Anderson-Fabry disease? Am J Cardiol 2010 0.81
58 Concurrent upregulation of endogenous proapoptotic and antiapoptotic factors in failing human hearts. Nat Clin Pract Cardiovasc Med 2009 0.80
59 Transcriptomic and proteomic analysis in the cardiovascular setting: unravelling the disease? J Cardiovasc Med (Hagerstown) 2009 0.80
60 Clinical utility gene card for: Marfan syndrome type 1 and related phenotypes [FBN1]. Eur J Hum Genet 2010 0.80
61 EDG3 and SHC3 on chromosome 9q22 are co-amplified in human ependymomas. Cancer Lett 2009 0.80
62 Structures of the lamin A/C R335W and E347K mutants: implications for dilated cardiolaminopathies. Biochem Biophys Res Commun 2012 0.79
63 Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy. J Am Coll Cardiol 2012 0.79
64 A novel mutation of the glomulin gene in an Italian family with autosomal dominant cutaneous glomuvenous malformations. Exp Dermatol 2011 0.79
65 Restrictive cardiomyopathy. Curr Opin Cardiol 2009 0.79
66 Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study. Thromb Haemost 2002 0.79
67 The influence of surgery, immunosuppressive drugs, and rejection, on graft function after small bowel transplantation: a large-animal study. Transpl Int 2003 0.79
68 Molecular imaging of misfolded protein pathology for early clues to involvement of the heart. Eur J Nucl Med Mol Imaging 2014 0.78
69 Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2004 0.78
70 Cell density modulates SHC3 expression and survival of human glioblastoma cells through Fak activation. J Neurooncol 2014 0.78
71 Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients. New Microbiol 2012 0.78
72 Quantification of manual thrombus removal in patients with acute coronary syndromes: a study exploiting serial frequency domain-optical coherence tomography. J Cardiovasc Med (Hagerstown) 2015 0.78
73 Extra-aortic identifiers to guide genetic testing in familial thoracic aortic aneurysms and dissections syndromes: it is all about the company one keeps. J Am Coll Cardiol 2012 0.77
74 POPDC1S201F causes muscular dystrophy and arrhythmia by affecting protein trafficking. J Clin Invest 2015 0.77
75 Heart transplantation in hypertrophic cardiomyopathy. Am J Cardiol 2007 0.77
76 Electroanatomic mapping and late gadolinium enhancement MRI in a genetic model of arrhythmogenic atrial cardiomyopathy. J Cardiovasc Electrophysiol 2014 0.77
77 Cyclosporin a in reperfusion injury: not opening to cell death knocking at the door? Ann Thorac Surg 2010 0.77
78 Cranial fasciitis with exclusive intracranial extension in an 8-year-old girl. Acta Neuropathol 2006 0.76
79 Coronary atherosclerosis in end-stage idiopathic dilated cardiomyopathy: an innocent bystander? Eur Heart J 2005 0.76
80 Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation. J Heart Lung Transplant 2002 0.76
81 A novel mtDNA point mutation in tRNA(Val) is associated with hypertrophic cardiomyopathy and MELAS. Ital Heart J 2004 0.76
82 Incidence of second primary cancer in transplanted patients. Transplantation 2006 0.76
83 [Consensus document on endomyocardial biopsy of the Associazione per la Patologia Cardiovascolare Italiana]. G Ital Cardiol (Rome) 2009 0.76
84 A method for morphological characterization of dural ectasia in Marfan syndrome. Conf Proc IEEE Eng Med Biol Soc 2009 0.76
85 Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy. Melanoma Res 2017 0.76
86 Similar Plaque Composition in Men and Women With Stable CAD: Another Myth Falls. JACC Cardiovasc Imaging 2016 0.75
87 Prevalence of J-point elevation in families with sudden arrhythmic death syndrome. J Am Coll Cardiol 2012 0.75
88 Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer. Photodermatol Photoimmunol Photomed 2013 0.75
89 Theranostic strategy against plaque angiogenesis. JACC Cardiovasc Imaging 2008 0.75
90 Human "nuclear" mitochondrial cardiomyopathy a novel mouse model characterizes the disease. JACC Cardiovasc Imaging 2011 0.75
91 Reply: The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: more questions than answers? J Am Coll Cardiol 2014 0.75
92 Reply: The importance of cardiac cycle in the imaging criteria for left ventricular noncompaction. J Am Coll Cardiol 2015 0.75
93 Letter by Maurizia Grasso et al. regarding article, "Restrictive cardiomyopathy with atrioventricular conduction block resulting from a desmin mutation". Int J Cardiol 2007 0.75
94 Pathology of plaque haemorrhage and neovascularization of coronary artery. J Cardiovasc Med (Hagerstown) 2012 0.75
95 Thromboaspiration during acute myocardial infarction in a heart transplant patient. J Cardiovasc Med (Hagerstown) 2008 0.75
96 Prevention of no-reflow phenomenon in culprit lesions involving a large side branch. Cardiovasc Interv Ther 2014 0.75
97 Minute pulmonary meningothelial-like nodules in the transbronchial biopsy of a lung transplant recipient. J Heart Lung Transplant 2005 0.75
98 The pathologic basis of recovery. Heart Fail Clin 2014 0.75
99 "My parents died of myocardial infarction: is that my destiny?". Med Clin North Am 2012 0.75
100 Atrial fibrillation and NPPA gene p.S64R mutation: are cardiologists helpless spectators of healthy mutation carriers? J Cardiovasc Med (Hagerstown) 2016 0.75
101 Enormous bi-atrial enlargement in a persistent idiopathic atrial standstill. Eur Heart J 2005 0.75
102 Cardio-Oncology: The Carney Complex Type I. J Am Coll Cardiol 2016 0.75
103 Fatal ventricular arrhythmias in a young male with unrecognized LQT3 and cardiolaminopathy. J Cardiovasc Med (Hagerstown) 2017 0.75
104 Incomplete penetrance of GLMN gene c.395-1G>C mutation in a family with glomuvenous malformations. Int J Dermatol 2014 0.75
105 Successful surgical management of invasive aspergillosis of the pulmonary arteries. Ann Thorac Surg 2008 0.75
106 Autosomal recessive paediatric sick sinus syndrome associated with novel compound mutations in SCN5A. Int J Cardiol 2012 0.75
107 Diagnosis of dilated cardiomyopathy: how to improve clinical and etiological definition. Ital Heart J Suppl 2002 0.75
108 Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic. Isr Med Assoc J 2014 0.75
109 [Genetic diagnosis of familial dilated cardiomyopathy]. Ital Heart J Suppl 2002 0.75
110 Clinicopathological correlates can predict acute myocarditis in patients with recent-onset heart failure: preliminary data. Ital Heart J 2002 0.75
111 Obstructive intramural coronary amyloidosis: a distinct phenotype of cardiac amyloidosis that can cause acute heart failure. Eur Heart J 2006 0.75
112 'Precision and personalized medicine,' a dream that comes true? J Cardiovasc Med (Hagerstown) 2017 0.75
113 Information technology solutions to support translational research on inherited cardiomyopathies. Stud Health Technol Inform 2011 0.75
114 A "stable" coronary plaque rupture documented by repeated OCT studies. JACC Cardiovasc Imaging 2013 0.75
115 Glomuvenous malformations with smooth muscle and eccrine glands: unusual histopathologic features in a familial setting. J Cutan Pathol 2014 0.75
116 Early diagnosis of Wilson Disease in a six-year-old child. J Pediatr 2006 0.75
117 Serial optical coherence tomography imaging of ACS-causing culprit plaques. EuroIntervention 2015 0.75
118 Monitoring of inosine monophosphate dehydrogenase activity and expression during the early period of mycophenolate mofetil therapy in de novo renal transplant patients. Drug Metab Pharmacokinet 2012 0.75
119 High prevalence of a screening-detected, HFE-unrelated, mild idiopathic iron overload in Northern Italy. Haematologica 2002 0.75
120 Aortic root 3D parametric morphological model from 2D-echo images. Comput Biol Med 2013 0.75
121 [New frontiers for an ancient disease: genetics of atrial fibrillation]. G Ital Cardiol (Rome) 2013 0.75
122 Reply: A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation. J Am Coll Cardiol 2017 0.75
123 [Classification of the cardiomyopathies]. Kardiol Pol 2008 0.75